Open in App
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.
Alivus Life Sciences Ltd.
NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Alivus Life Sciences Ltd. (formerly Glenmark Life Sciences Ltd.) is a manufacturer and developer of high-value, non-commoditized Active Pharmaceutical Ingredients (APIs). The company focuses on chronic therapeutic areas, including cardiovascular dise...

Read More
Ask MarketMind AI
1350.20 -8.00 (-0.59%)
Near 52W High of ₹1418.00
55,966
NSE+BSE Volume

NSE 28 Aug, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Dividend
Alivus Life Sciences has an upcoming dividend of ₹5.000 per share due on 01 Sep 2026 See details
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
High Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Moderately Bullish
63.2 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
1,359
1Yr Price target upside is 1%
4 analysts

19

S

8

W

3

O

3

T

SWOT Analysis

Alivus Life Sciences Live Price Chart

Switch to TradingView
Switch to

Alivus Life Sciences Live Price Chart

Custom


Loading Fundamental data..


Loading data..
VOTE: Is Glenmark Life Sciences Ltd. worth buying?
134 Votes:
Buy 75.37%
Sell 11.94%
Hold 12.69%
BUY
SELL
HOLD
Ask AI
×